Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Aramchol and Food Effect in Healthy Volunteers
NCT02374437Phase 1Completed
- Sponsor
- Galmed Pharmaceuticals
- Start
- Apr 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of aramchol in Nonalcoholic steatohepatitis (NASH) (8 arms), sponsored by Galmed Pharmaceuticals. Primary endpoints: Maximum Plasma Concentration at Day 10 and Area Under the Plasma Concentration Time Curve at Day 10. Started Apr 2014; status: completed.
02
Drugs
aramchol
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02374437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374437.